WB result of p73 alpha + beta Recombinant Rabbit mAb
Primary antibody: p73 alpha + beta Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: HEK-293 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 70 kDa
Observed MW: 60, 70 kDa
Product Details
Product Details
Product Specification
| Host | Rabbit |
| Antigen | p73 alpha + beta |
| Synonyms | Tumor protein p73; p53-like transcription factor; p53-related protein; P73; TP73 |
| Immunogen | Synthetic Peptide |
| Location | Cytoplasm, Nucleus |
| Accession | O15350 |
| Clone Number | S-2565-27 |
| Antibody Type | Recombinant mAb |
| Isotype | IgG |
| Application | WB |
| Reactivity | Hu |
| Positive Sample | HEK293, MCF7 |
| Predicted Reactivity | Mk, Ms |
| Purification | Protein A |
| Concentration | 2 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300 |
| Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
| application | dilution | species |
| WB | 1:1000 | Hu |
Background
The p73 alpha + beta proteins collectively denote the two major N-terminal transactivation-domain isoforms encoded by the human TP73 gene: the full-length TAp73α (containing an N-terminal TA domain, DNA-binding domain, oligomerization domain, and a long C-terminal sterile α-motif, SAM domain) and its shorter splice variant TAp73β, which retains the TA, DBD and OD but lacks the C-terminal SAM extension; both act as p53-like tumor suppressors, binding canonical p53-response elements to activate transcription of pro-apoptotic and cell-cycle arrest genes, yet they also exhibit isoform-specific roles in neuronal development, DNA damage response, chemosensitivity, and metabolic regulation, with α being more abundant in post-mitotic neurons and β predominating in proliferating epithelia, while their expression is tightly controlled through alternative promoter usage and extensive C-terminal splicing that yields additional dominant-negative ΔNp73 isoforms that antagonize the α/β tumor-suppressive activities under stress conditions.
Picture
Picture
Western Blot
WB result of p73 alpha + beta Recombinant Rabbit mAb
Primary antibody: p73 alpha + beta Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated MCF7 whole cell lysate 20 µg
Lane 2: MCF7 treated with 0.5μM doxorubicin for 24 hours whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 70 kDa
Observed MW: 60, 70 kDa
This blot was developed with high sensitivity substrate
